Vaccine Products

Highlight

• The 1st COVID-19 Inhaled Vaccine
• Triple immunity, better protection (Triggers cellular, humoral and mucosal immune )
• No injection, easy vaccination
• Reduce needle-stick, decrease operational risk
• Good safety, no injection-site adverse events

Indication

Prevent the COVID-19 disease caused by the SARS-CoV-2 virus for adults age 18 years and older

Highlight

• WHO Pre-qualified
• Porcine Free
• Fast-acting and Long-lasting protection
• Extesive use in more than 20 countries
• Well-tolerated Few adverse reactions

Indication

Hepatitis A Vaccine for Children 1 Year – 15 Year, Hepatitis A Vaccine for adult > 16 years.

Highlight

• The 1st mRNA Vaccine produced locally in Indonesia
• The 1st Halal mRNA Vaccine

Indication

For active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

Highlight

• 3rd MCV4 in the world
• Conjugated vaccine with robust immunogenicity profile and provides longer protection results
• High Quality
• Menhycia has been received Halal Decree & Certificate by MUI

Indication

Active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A,C,Y and W.

Highlight

• WHO Pre-qualifiedWHO Pre-qualified
• High Quality
• Persistent protection against infection of HPV types 16 and 18

Indication

Prevent cervical cancer, cervical intraepithelial neoplasia (CIN) grade 2 or grade 3, and cervical adenocarcinoma in situ (AIS) caused by high-risk HPV types 16 and 18 in females 9 through 30 years of age.

Highlight

• 1st PCV 13 Local manufactured In Indonesia
• Valenina has been received Halal Decree & Certificate by MUI
• Valenina has been approved for Local Clinical Trial

Indication

Pneumococal Conjugate Vaccine prevent invasive disease caused by 13 serotypes.